LOGIN
Zoledronate reduces radiation-induced bone collagen degradation in radiation therapy
August 2020
Zoledronate reduces radiation-induced bone collagen degradation in radiation therapy
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial
Clin Transl Oncol. 2015 Jun;17(6):454-61.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty patients with skeletal metastasis who were scheduled to undergo local radiotherapy were included in this study. The purpose of the study was to determine the effect of zoledronate, a bisphosphonate, in collagen breakdown and bone loss secondary to radiation therapy. Patients were randomized to receive the first dose of the zoledronate either before, or after radiotherapy treatment. Findings ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.